Glucose Health Inc
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in… Read more
Glucose Health Inc (GLUC) - Total Liabilities
Latest total liabilities as of September 2025: $535.66K USD
Based on the latest financial reports, Glucose Health Inc (GLUC) has total liabilities worth $535.66K USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Glucose Health Inc - Total Liabilities Trend (2007–2024)
This chart illustrates how Glucose Health Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Glucose Health Inc Competitors by Total Liabilities
The table below lists competitors of Glucose Health Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WACKER CHEMIE - Dusseldorf Stock Exchang
DU:WCH
|
Germany | €4.27 Billion |
|
M Vision Public Company Limited
BK:MVP
|
Thailand | ฿182.77 Million |
|
SYSCO - Dusseldorf Stock Exchang
DU:SYY
|
Germany | €23.64 Billion |
|
Avenue Therapeutics Inc
PINK:ATXI
|
USA | $1.42 Million |
|
ITRON (IT6.SG)
STU:IT6
|
Germany | €2.00 Billion |
|
Archidply Decor Limited
NSE:ADL
|
India | ₹245.74 Million |
|
Quality Online Education Group Inc
PINK:QOEG
|
USA | $5.37 Million |
Liability Composition Analysis (2007–2024)
This chart breaks down Glucose Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.83 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Glucose Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Glucose Health Inc (2007–2024)
The table below shows the annual total liabilities of Glucose Health Inc from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $387.32K | +174.61% |
| 2023-12-31 | $141.05K | +570.51% |
| 2022-12-31 | $21.04K | +120.16% |
| 2021-12-31 | $9.55K | -96.85% |
| 2020-12-31 | $303.53K | -20.26% |
| 2019-12-31 | $380.65K | -32.03% |
| 2018-12-31 | $560.00K | +21.87% |
| 2017-12-31 | $459.49K | -13.07% |
| 2016-12-31 | $528.59K | +31.09% |
| 2015-12-31 | $403.23K | +24.23% |
| 2014-12-31 | $324.58K | +45.33% |
| 2013-12-31 | $223.35K | +20.42% |
| 2012-12-31 | $185.48K | -55.81% |
| 2011-12-31 | $419.70K | -38.49% |
| 2010-12-31 | $682.36K | +46.27% |
| 2009-12-31 | $466.51K | +175.98% |
| 2008-12-31 | $169.04K | +1083.67% |
| 2007-12-31 | $14.28K | -- |